Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy

BACKGROUND: Prior studies have evaluated the use of various constituents of cannabis for their anti-seizure effects. Specifically, cannabidiol, a non-psychoactive component of cannabis, has been investigated for treatment-resistant epilepsy, but more information is needed particularly on its use in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:CNS Drugs
Päätekijät: Wheless, James W., Dlugos, Dennis, Miller, Ian, Oh, D. Alexander, Parikh, Neha, Phillips, Steven, Renfroe, J. Ben, Roberts, Colin M., Saeed, Isra, Sparagana, Steven P., Yu, Jin, Cilio, Maria Roberta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2019
Aiheet:
Original Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534520/
https://ncbi.nlm.nih.gov/pubmed/31049885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00624-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia